SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-050374
Filing Date
2014-08-04
Accepted
2014-08-04 18:17:50
Documents
1
Period of Report
2014-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2137
  Complete submission text file 0001209191-14-050374.txt   3990
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address GUIHAU NORTH ROAD, NO. 132 GONGBEI ZHUHAI CITY F4 519020
Business Address GUIHAU NORTH ROAD, NO. 132 GONGBEI ZHUHAI CITY F4 519020 0756-8135105
Livzon MABPharm Inc. (Reporting) CIK: 0001615554 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51171 | Film No.: 141014222